AI assistant
Sending…
Athira Pharma, Inc. — Director's Dealing 2022
Jun 30, 2022
35038_dirs_2022-06-30_66e887fa-8dee-4d09-8e9c-dc6d6324c6a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2022-06-28
Reporting Person: MOEBIUS HANS (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-28 | Common Stock | P | 10000 | $2.88 | Acquired | 52955 | Direct |
More from Athira Pharma, Inc.
Annual Report
2026
May 11
Registration Form
2026
Apr 1
Registration Form
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Feb 23
Major Shareholding Notification
2026
Feb 6
Registration Form
2026
Jan 20
Registration Form
2026
Jan 20